Advertisement
U.S. markets closed

Virgin Galactic Holdings, Inc. (SPCE)

NYSE - Nasdaq Real Time Price. Currency in USD
1.6500-0.0200 (-1.20%)
At close: 04:00PM EST
1.6600 +0.01 (+0.61%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close1.6700
Open1.7000
Bid1.6500 x 21500
Ask1.6500 x 36900
Day's Range1.6100 - 1.7200
52 Week Range1.3800 - 6.1680
Volume9,191,717
Avg. Volume10,207,736
Market Cap659.53M
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SPCE

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Virgin Galactic Holdings, Inc.
    Analyst Report: Moderna, Inc.Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
    Rating
    Fair Value
    Economic Moat
    2 days agoMorningstar
View more